Distributed Pharmaceutical Manufacturing Environment Monitoring System Using Hybrid Communication Channel: A Layered Software Architecture Approach

Authors

  • Dr. Pramod U. Chavan, Dr. Ramadevi R., Dr. M.Murugan, Pratibha P. chavan

Abstract

The novel contribution of this paper is to address the key issues of pharmaceutical automation like efficiency, productivity, production time, decision making, scalability, testability, etc. for pharmaceutical process automation. It aimed to develop and deploy a Layered Software Architecture (LSA) on Distributed Pharmaceutical Manufacturing Environment Monitoring System (DPMEMS) with effective utilization of hardware and software resources. The system consists of the master and spatially distributed heterogeneous slave units communicated using Hybrid Communication Channel (HCC). The feasibility of system performance,in terms of the average round-trip time, estimated using histogram and probability distributions, validates the LSA for distributed monitoring and control in the modern DPMEMS. The LSA eases the identification and elimination of premature flaws before the actual system has been built. Hence, the proposed architecture suggests flexibility in the design lessening configuration time, cost and less vulnerability to errors.

Published

2021-08-19

How to Cite

Dr. Pramod U. Chavan, Dr. Ramadevi R., Dr. M.Murugan, Pratibha P. chavan. (2021). Distributed Pharmaceutical Manufacturing Environment Monitoring System Using Hybrid Communication Channel: A Layered Software Architecture Approach. Drugs and Cell Therapies in Hematology, 10(1), 1537–1548. Retrieved from http://www.dcth.org/index.php/journal/article/view/300

Issue

Section

Articles